DCO
28.8.2024 21:46:33 CEST | Business Wire | Press release
The Digital Cooperation Organization (DCO), a global multilateral organization committed to enabling digital prosperity for all by accelerating the sustainable and inclusive growth of the digital economy, hosted a strategic roundtable discussion with major technology companies, and social media and digital platform representatives to address the societal impact of the spread of online misinformation.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240828374432/en/
Representatives from social media, technology companies, and digital platforms at the DCO HQ (Photo AETOSWire)
Building on the series of global roundtables conducted in 2023 as part of the “combating online misinformation” Digital Space Accelerators, this roundtable continuous the DCO’s ongoing efforts to combat online misinformation. Representatives from Google, LinkedIn, Meta and TikTok participated as key stakeholders to discuss this crucial issue affecting the digital world.
The roundtable, held at the DCO headquarters in Riyadh, Saudi Arabia, aimed to identify challenges and propose innovative solutions to foster trust and safeguard the digital economy. The participation of representatives from social media and digital platforms underscored the importance of the roundtable, providing a crucial platform for stakeholders to exchange perspectives and explore collaborative actions to combat online misinformation.
The discussions aimed to create an ongoing dialogue on the gravity of online misinformation as both a societal problem and a challenge to the digital economy. It also provided a platform for stakeholders to bridge their perspectives and work together to combat online misinformation, thereby ensuring a trustworthy digital information ecosystem.
"The exchange of ideas and insights from leading platforms has been invaluable. The key takeaway from the discussion was the importance of cooperation through a multistakeholder approach to combat online misinformation, which aligns with the DCO’s mission. We are confident that the outcomes of this roundtable will pave the way for a more informed and resilient digital society, and we look forward to our next collaborative roundtable to enable digital prosperity for all", said Alaa Abdulaal, Chief of the Digital Economy Foresight department at the Digital Cooperation Organization.
Sarah Al-Husseini, Head of Government Affairs & Public Policy, KSA at Google, said: “People come to Google because they trust they will be able to find high quality information, which is why we take our commitment to combating misinformation through our products and our content policies very seriously. We work hard to retain that trust - designing our systems for quality and ensuring users are given access to a range of information from different voices and the tools to know what they can trust. We do not do it alone; in addition to continuously adapting our policies and technologies to prevent abuse, we openly share our technology and collaborate with experts to drive the industry forward and create a safer internet for everyone.”
Ranim Alamin, Strategic Government Partnerships Head, KSA at LinkedIn, said: “Taking part in the DCO's strategic roundtable offered us a valuable opportunity to discuss one of the more pressing issues in the digital world: Misinformation. The conversations we had with representatives from various leading platforms underscored the importance of a united approach to foster trust. We are committed to working together to build a more trusted and resilient digital information ecosystem.”
Tom Bonsundy-O'Bryan, Misinformation Policy, EMEA Lead at Meta, said: “We were glad to attend this roundtable organized by the DCO and remain deeply committed to tackling misinformation - balancing our values of expression, safety, authenticity and privacy.”
Hatem Samman, Executive Director of Government Relations & Public Policy, KSA at TikTok, said: “At TikTok, we are committed to fostering a secure and trustworthy digital environment for the community. This roundtable provided an essential platform for discussing innovative strategies and collaborative actions to combat misinformation. By working together, we can create a safe, authentic space where people can discover content that is original and engage with people who are authentic.”
The Digital Cooperation Organization remains committed to fostering a collaborative approach to combating misinformation and ensuring the growth of the digital economy. The DCO looks forward to continuing this impactful work with its partners in the social media and digital platform space.
*Source: AETOSWire
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240828374432/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces Positive CHMP Opinion for Opzelura® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 13:30:00 CEST | Press release
If approved, Opzelura® (ruxolitinib) cream will be the first steroid-free, topical JAK treatment option in the European Union (EU) for adults with moderate atopic dermatitis (AD) for whom standard topical therapies have failedAD, the most common type of eczema which affects 230 million people globally,1 is a chronic, recurring, inflammatory and highly pruritic (itchy) skin condition that can have a significant impact on daily life2Phase 3 TRuE‑AD4 data supporting the positive CHMP opinion demonstrated that ruxolitinib cream met both co‑primary endpoints at Week 8, maintained disease control with as-needed treatment through Week 24 and was well tolerated3,4,5 Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids
Datroway® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 13:00:00 CEST | Press release
Recommendation based on TROPION-Breast02 phase 3 trial where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival If approved, Datroway has potential to be the first TROP2 directed antibody drug conjugate for patients in EU with a demonstrated overall survival benefit as first-line treatment Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use
DAYBU®(trofinetide) Recommended for Approval in the European Union by CHMP26.6.2026 12:49:00 CEST | Press release
-- European Commission decision expected in the coming months-- If approved, DAYBU®would become the first treatment for neurobehavioral symptoms of Rett syndrome in the European Union Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion following a re-examination procedure, recommending the granting of a marketing authorization for DAYBU® (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older. If granted marketing authorization by the European Commission, DAYBU® would be the first therapy approved for this indication in the European Union (EU). “The CHMP’s positive opinion for DAYBU® is an important milestone in our mission to bring this innovative therapy to the EU, where there are no therapies specifically approved for the neurobehavioral symptoms of this devastating
HTEC Showcases Lakebase Branching at Databricks’ Data & AI Summit26.6.2026 11:18:00 CEST | Press release
HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. The Solution was developed in collaboration with a leading risk and compliance technology provider who serves financial institutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260626875859/en/ HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. Solving Critical Development Bottlenecks in Regulated Environments At the core of the collaboration was a shared challenge: how to enable modern data workflows in an envi
Stallergenes Greer Named One of Switzerland’s Best Managed Companies for 202626.6.2026 10:28:00 CEST | Press release
Stallergenes Greer, a global leader in allergy care, has been recognised for its overall business performance, company culture, and sustained growth by receiving the prestigious 2026 Switzerland’s Best Managed Companies award. The 2026 Best Managed Companies programme award winners are among Switzerland’s best private companies. The awards are derived from Deloitte’s global Best Managed Companies awards programme, an internationally recognised programme that evaluates businesses based on their leadership in the areas of strategy, culture and commitment, capabilities, innovation, governance and financial performance. Applicants are evaluated by an independent jury of experts. The evaluation of the Switzerland awards is based on more than 30 years of observed practice from the global awards programme that has been rolled out in 50+ countries worldwide. This recognition reflects Stallergenes Greer's consistent ability to deliver on its strategic vision while maintaining the operational di
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
